-
Shanghai Enhances Biomedicine IP Protection with New Procurement-Linked Measures
•
The Shanghai Intellectual Property Administration (SIPA) has issued a notification highlighting the city’s intensified efforts to protect intellectual property (IP) rights within the biomedicine industry. This strategic move comes on the heels of several high-profile administrative rulings on biopharmaceutical patent infringement disputes in Shanghai, underscoring a commitment to a linkage…
-
China’s NHSA Aims to Balance Drug Prices with New Monitoring System by March 2024
•
The National Healthcare Security Administration (NHSA) has issued a notification aimed at fostering inter-provincial price fairness, integrity, transparency, and balance for drugs sharing the same generic names and manufacturers. The initiative involves a comprehensive review and inspection of drugs based on four criteria: generic name, manufacturer, dosage form, and specification.…
-
Jiangsu Initiates Sunshine Procurement Round for Medical Consumables with 46 Products
•
The Jiangsu Public Resource Trading Platform has announced a new round of sunshine online procurement for medical consumables, which includes 46 products from 36 different manufacturers. This procurement process aligns online procurement prices with those in 25 provinces and municipalities, ensuring that the lowest price within the reference group is…
